NASDAQ:IMACIMAC Stock Price, Forecast & News

$1.59

-0.04 (-2.45 %)

(As of 05/27/2020 04:00 PM ET)

Add

Compare

Today's Range

$1.57

Now: $1.59▼

$1.65

50-Day Range

$1.36

MA: $1.58▼

$1.78

52-Week Range

$0.42

Now: $1.59▼

$5.50

Volume80,691 shs

Average Volume749,715 shs

Market Capitalization$15.91 million

P/E RatioN/A

Dividend YieldN/A

Beta-3.8

IMAC Holdings, Inc. operates a chain of integrated medicine and chiropractic regeneration centers. The company's outpatient clinics provide regenerative, orthopedic, and minimally invasive procedures and therapies to patients with back pain, knee pain, joint pain, ligament and tendon damage, and other related soft tissue conditions. As of September 17, 2018, it had 11 clinics, including 6 owned and 5 managed clinics in Kentucky, Missouri, and Tennessee, the United States. The company was founded in 2000 and is based in Brentwood, Tennessee.

Beat the Market (BTM) Rank^™

3.3 Analyst's Opinion

Consensus Rating
IMAC has received a consensus rating of Buy. The company's average rating score is 2.50, and is based on 1 buy rating, 1 hold rating, and no sell ratings.
Price Target Upside/Downside
According to analysts' consensus price target of $4.50, IMAC has a potential upside of 183.0% from its current price of $1.59.
Amount of Analyst Coverage
IMAC has only been the subject of 1 research reports in the past 90 days.

2.2 Community Rank

Outperform Votes
IMAC has received 68 “outperform” votes. (Add your “outperform” vote.)
Underperform Votes
IMAC has received 84 “underperform” votes. (Add your “underperform” vote.)
Community Sentiment
IMAC has received 55.26% “underperform” votes from our community.

MarketBeat's community ratings are surveys of what our community members think about IMAC and other stocks. Vote “Outperform” if you believe IMAC will outperform the S&P 500 over the long term. Vote “Underperform” if you believe IMAC will underperform the S&P 500 over the long term. You may vote once every thirty days.

0.0 Dividend Strength

Dividend Yield
IMAC does not currently pay a dividend.
Dividend Growth
IMAC does not have a long track record of dividend growth.

3.0 Company Ownership

Insider Buying vs. Insider Selling
In the past three months, IMAC insiders have bought more of their company's stock than they have sold. Specifically, they have bought $1,450.00 in company stock and sold $0.00 in company stock.
Percentage Held by Institutions
Only 0.59% of the stock of IMAC is held by institutions.

0.0 Earnings and Valuation

Price to Earnings Ratio vs. the Market
The P/E ratio of IMAC is -2.15, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Earnings Ratio vs. Sector
The P/E ratio of IMAC is -2.15, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Book Value per Share Ratio
IMAC has a P/B Ratio of 2.18. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

Overall Beat the Market Rank^™

1.69 out of 5 stars

Industry, Sector and Symbol

Stock Exchange NASDAQ

Industry Specialty outpatient clinics, not elsewhere classified

Sub-IndustryN/A

SectorMedical

Current SymbolNASDAQ:IMAC

Previous Symbol

CUSIPN/A

CIKN/A

Webwww.imacregeneration.com

Phone844-266-4622

Debt

Debt-to-Equity Ratio0.56

Current Ratio0.38

Quick Ratio0.38

Price-To-Earnings

Trailing P/E RatioN/A

Forward P/E RatioN/A

P/E GrowthN/A

Sales & Book Value

Annual Sales$15.13 million

Price / Sales1.05

Cash FlowN/A

Price / Cash FlowN/A

Book Value$0.73 per share

Price / Book2.18

Profitability

EPS (Most Recent Fiscal Year)($0.84)

Net Income$-6,500,000.00

Net Margins-41.20%

Return on Equity-80.08%

Return on Assets-30.42%

Miscellaneous

EmployeesN/A

Outstanding Shares10,009,000

Market Cap$15.91 million

Next Earnings Date8/21/2020 (Estimated)

OptionableNot Optionable

Receive IMAC News and Ratings via Email

Sign-up to receive the latest news and ratings for IMAC and its competitors with MarketBeat's FREE daily newsletter.

IMAC (NASDAQ:IMAC) Frequently Asked Questions

How has IMAC's stock been impacted by COVID-19 (Coronavirus)?

IMAC's stock was trading at $0.82 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, IMAC shares have increased by 93.9% and is now trading at $1.59. View which stocks have been most impacted by Coronavirus.

Do Wall Street analysts recommend investors buy shares of IMAC?

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for IMAC in the last year. There are currently 1 hold rating and 1 buy rating for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for IMAC.

When is IMAC's next earnings date?

IMAC is scheduled to release its next quarterly earnings announcement on Friday, August 21st 2020. View our earnings forecast for IMAC.

How were IMAC's earnings last quarter?

IMAC Holdings Inc (NASDAQ:IMAC) announced its earnings results on Thursday, May, 14th. The company reported ($0.18) EPS for the quarter, missing analysts' consensus estimates of ($0.17) by $0.01. The company earned $3.32 million during the quarter, compared to the consensus estimate of $5.72 million. IMAC had a negative net margin of 41.20% and a negative return on equity of 80.08%. View IMAC's earnings history.

What price target have analysts set for IMAC?

2 brokerages have issued 1 year price targets for IMAC's shares. Their forecasts range from $4.50 to $4.50. On average, they expect IMAC's stock price to reach $4.50 in the next twelve months. This suggests a possible upside of 183.0% from the stock's current price. View analysts' price targets for IMAC.

Has IMAC been receiving favorable news coverage?

News coverage about IMAC stock has been trending somewhat negative recently, according to InfoTrie. InfoTrie identifies negative and positive news coverage by reviewing more than six thousand blog and news sources. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores nearest to five being the most favorable. IMAC earned a daily sentiment score of -1.0 on InfoTrie's scale. They also gave news coverage about the company a news buzz of 0.0 out of 10, meaning that recent news coverage is extremely unlikely to have an effect on the company's share price in the next few days. View the latest news aboutIMAC.

Are investors shorting IMAC?

IMAC saw a decline in short interest in May. As of May 15th, there was short interest totaling 46,800 shares, a decline of 45.8% from the April 30th total of 86,400 shares. Based on an average daily trading volume, of 1,070,000 shares, the short-interest ratio is presently 0.0 days. Currently, 0.9% of the shares of the stock are short sold. View IMAC's Current Options Chain.

Who are some of IMAC's key competitors?

Some companies that are related to IMAC include Acadia Healthcare (ACHC), BioTelemetry (BEAT), Hanger (HNGR), Biocorrx (BICX) and AAC (AAC). View all competitors.

What other stocks do shareholders of IMAC own?

Based on aggregate information from My MarketBeat watchlists, some companies that other IMAC investors own include NovaBay Pharmaceuticals (NBY), NovaBay Pharmaceuticals (NBY), Amarin (AMRN), VBI Vaccines (VBIV), Advanced Micro Devices (AMD), Aytu Bioscience (AYTU), Crispr Therapeutics (CRSP), Vaxart (VXRT), Agile Therapeutics (AGRX) and Armata Pharmaceuticals (ARMP).

Who are IMAC's key executives?

IMAC's management team includes the following people:

Mr. Jeffrey S. Ervin M.B.A., CEO & Director (Age 41)
Mr. D. Anthony Bond CPA, Chief Financial Officer (Age 57)
Dr. Matthew C. Wallis, COO & Director (Age 45)
Mr. Jeff Ervin, Chief Exec. Officer
Dr. Ian A. White Ph.D., Chief Scientific Officer (Age 44)

When did IMAC IPO?

(IMAC) raised $4 million in an initial public offering on the week of February 11th 2019. The company issued 900,000 shares at a price of $5.00 per share. Dawson James Securities and Cuttone served as the underwriters for the IPO.

What is IMAC's stock symbol?

IMAC trades on the NASDAQ under the ticker symbol "IMAC."

How do I buy shares of IMAC?

Shares of IMAC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is IMAC's stock price today?

One share of IMAC stock can currently be purchased for approximately $1.59.

How big of a company is IMAC?

IMAC has a market capitalization of $15.91 million and generates $15.13 million in revenue each year. The company earns $-6,500,000.00 in net income (profit) each year or ($0.84) on an earnings per share basis.

What is IMAC's official website?

The official website for IMAC is www.imacregeneration.com.

How can I contact IMAC?

IMAC's mailing address is 1605 WESTGATE CIRCLE, BRENTWOOD TN, 37027. The company can be reached via phone at 844-266-4622 or via email at [email protected]

This page was last updated on 5/27/2020 by MarketBeat.com Staff